Table: Aska Pharmaceutical Holdings - 6-MTH group results

ASKA Pharmaceutical Holdings

07/11/2022 06:00

Nov 7 (Reuters)- 
             Aska Pharmaceutical Holdings Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             30.17               28.48            60.00    
                 (+6.0 pct)                           (+6.0 pct)  
  Operating          2.88                2.66             5.20    
                 (+8.3 pct)                           (+8.4 pct)  
  Recurring          2.99                2.74             5.30    
                 (+8.9 pct)                           (+8.6 pct)  
  Net                2.35             loss 2.80           4.20    
                                                      (-2.1 pct)  
  EPS             83.18 yen        loss 98.52 yen     148.88 yen  
  Ann Div                             15.00 yen        16.00 yen  
  -Q2 div         8.00 yen            7.00 yen                    
  -Q4 div                             8.00 yen         8.00 yen   
  
  NOTE - Aska Pharmaceutical Holdings Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T